BTIG Reiterates Buy Rating on Stryker Corporation (SYK)

Market Context

Stryker Corporation operates in the Healthcare sector. The stock currently trades at $323.28 with a market capitalization of $135.0B. The stock has declined 2.2% over the past 52 weeks.

Analyst coverage from BTIG provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Stryker Corporation.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Stryker Corporation

Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Jul 31, 2026	Truist Securities	Hold	N/A
Jul 31, 2026	BTIG	Buy	N/A
Jul 09, 2026	BMO Capital	Outperform	N/A
Jul 06, 2026	Evercore ISI Group	Outperform	N/A
Jun 05, 2026	Leerink Partners	Outperform	N/A

Related Tools: Analyst Ratings Dashboard | View SYK Stock Page